Literature DB >> 31468249

Comparison of the Effectiveness of Two Cognitive-Behavioral Group Therapy Programs for Schizophrenia: Results of a Short-Term Randomized Control Trial.

Oya Mortan Sevi1, Serap Tekinsav Sutcu2, Sema Yesilyurt3, Sultan Turan Eroglu4, Busra Gunes5.   

Abstract

This study aimed to compare the effectiveness of two different cognitive-behavioural therapy programs in patients with schizophrenia and clarify which techniques are more effective on psychotic symptoms. With this purpose, 39 schizophrenia outpatients-assessed by independent assessors using Scale for the Assessment of Positive Symptoms, Scale for the Assessment of Negative Symptoms and by researchers using Psychotic Symptoms Rating Scales-were randomly assigned to routine care (RC), RC plus COPE-CBT or RC plus CBT groups. The repeated measures ANOVA results show that there was a significant reduction in the severity and frequency of hallucinations in CBT group and delusions in COPE-CBT group. Both CBT programs were found to be superior to RC group on some measures at post-treatment, as well as 3 months follow-up.

Entities:  

Keywords:  Cognitive behavioural therapy; Effectiveness; Randomized controlled trial; Schizophrenia; Treatment

Mesh:

Year:  2019        PMID: 31468249     DOI: 10.1007/s10597-019-00448-y

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  25 in total

1.  Cognitive therapy of schizophrenia: a new therapy for the new millennium.

Authors:  A T Beck; N A Rector
Journal:  Am J Psychother       Date:  2000

2.  The significance of coping as a therapeutic variable for the outcome of psychological therapy in schizophrenia.

Authors:  Karl Andres; Mario Pfammatter; Alexander Fries; Hans Dieter Brenner
Journal:  Eur Psychiatry       Date:  2003-06       Impact factor: 5.361

3.  Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life.

Authors:  Andreas Bechdolf; Bärbel Knost; Barnaby Nelson; Nicola Schneider; Verena Veith; Alison R Yung; Ralf Pukrop
Journal:  Aust N Z J Psychiatry       Date:  2010-02       Impact factor: 5.744

4.  Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis.

Authors:  Alison R Yung; Lisa J Phillips; Barnaby Nelson; Shona M Francey; Hok PanYuen; Magenta B Simmons; Margaret L Ross; Daniel Kelly; Kathryn Baker; G Paul Amminger; Gregor Berger; Andrew D Thompson; Annette Thampi; Patrick D McGorry
Journal:  J Clin Psychiatry       Date:  2010-10-19       Impact factor: 4.384

5.  Further evidence for the efficacy of a metacognitive group training in schizophrenia.

Authors:  S Moritz; A Kerstan; R Veckenstedt; S Randjbar; F Vitzthum; C Schmidt; M Heise; T S Woodward
Journal:  Behav Res Ther       Date:  2010-12-07

6.  Negative symptoms in schizophrenia. Definition and reliability.

Authors:  N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1982-07

7.  Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS).

Authors:  G Haddock; J McCarron; N Tarrier; E B Faragher
Journal:  Psychol Med       Date:  1999-07       Impact factor: 7.723

8.  [Family centered evaluation of treatment outcome in schizophrenia: Marmara Family Interview for the Assesment of Psychiatric Treatment].

Authors:  M Kemal Kuşçu; Zekiye Cetinkaya Duman; Mehmet Akman; Alp Uçok; Esat O Göktepe
Journal:  Turk Psikiyatri Derg       Date:  2006

9.  Cognitive behavioural group treatment for social anxiety in schizophrenia.

Authors:  Patrick Kingsep; Paula Nathan; David Castle
Journal:  Schizophr Res       Date:  2003-09-01       Impact factor: 4.939

10.  [The Assessment of the Auditory Hallucinations and Delusions: The Reliability and the Validity of Turkish Version of the Psychotic Symptom Rating Scales (PSYRATS)].

Authors:  Oya Mortan Sevi; Serap Tekinsav Sütcü; Büşra Güneş
Journal:  Turk Psikiyatri Derg       Date:  2016
View more
  1 in total

Review 1.  Cognitive behavioural therapy (group) for schizophrenia.

Authors:  Giuseppe Guaiana; Massimiliano Abbatecola; Ghazaleh Aali; Federica Tarantino; Ikenna D Ebuenyi; Valeria Lucarini; Wei Li; Caidi Zhang; Antonio Pinto
Journal:  Cochrane Database Syst Rev       Date:  2022-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.